Press coverage about Intermolecular (NASDAQ:IMI) has been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intermolecular earned a news sentiment score of 0.26 on Accern’s scale. Accern also assigned headlines about the semiconductor company an impact score of 45.1540911825201 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Separately, ValuEngine upgraded Intermolecular from a “strong sell” rating to a “sell” rating in a research report on Monday.

Intermolecular (IMI) traded down 1.7292% on Tuesday, hitting $0.9434. The stock had a trading volume of 16,261 shares. The firm’s market cap is $46.75 million. Intermolecular has a 52-week low of $0.78 and a 52-week high of $1.30. The company’s 50 day moving average price is $0.95 and its 200 day moving average price is $0.95.

In related news, major shareholder Lloyd I. Miller III bought 80,000 shares of Intermolecular stock in a transaction dated Thursday, June 22nd. The shares were acquired at an average cost of $0.88 per share, with a total value of $70,400.00. Following the completion of the transaction, the insider now owns 70,368 shares in the company, valued at approximately $61,923.84. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders purchased a total of 165,599 shares of company stock worth $143,226 over the last three months. 15.20% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Intermolecular (NASDAQ:IMI) Getting Positive News Coverage, Analysis Finds” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with's FREE daily email newsletter.